Finland Biotechnology & Medical Research

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy recorded its most recent insider trading activity on March 1, 2026. During this period, key personnel including Sirpa Jalkanen and Tuomo Pätsi executed purchase orders. No further transactions have occurred within the last three months, indicating a period of inactivity regarding equity movements by company leadership.
Ticker: FARN Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Faron Pharmaceuticals Oy. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Tuomo Pätsi Non-Executive Chairman Director
Transaction date
Purchase
Price
13.79
Quantity 59,740
Value €1,156,483
Sirpa Jalkanen PCA
Transaction date
Purchase
Price
265.53
Quantity 87,167
Value €1,791,182
Tuomo Pätsi Director Executive Director
Transaction date
Purchase
Price
258.14
Quantity 12,958
Value €3,795,489
Sirpa Jalkanen Director Executive Director
Transaction date
Purchase
Price
1.50
Quantity 79,999
Value €119,998
2.2
Markku Jalkanen Director Executive Director
Transaction date
Purchase
Price
1.50
Quantity 79,999
Value €119,998
John Poulos Non-executive Director Executive Director
Transaction date
Sale
Price
3.83
Quantity 5,000
Value €19,130
John Poulos Non-executive Director Executive Director
Transaction date
Sale
Price
3.72
Quantity 5,000
Value €18,604
2.2
Markku Jalkanen Chief Executive Officer Officer
Transaction date
Purchase
Price
2.82
Quantity 25,000
Value €70,532
2.4
Toni HÄonninen Chief Financial Officer Officer
Transaction date
Purchase
Price
3.51
Quantity 4,400
Value £15,444
2.4
Toni HÄonninen Chief Financial Officer Officer
Transaction date
Purchase
Price
4.33
Quantity 3,500
Value €15,139
1.0
Matti Karvonen VP Drug Development, Chief Medical Officer Officer
Transaction date
Purchase
Price
0.83
Quantity 20,000
Value £16,580
1.4
Minja Pfeiffer Chief Medical Officer Officer
Transaction date
Purchase
Price
1.00
Quantity 4,414
Value £4,414
3.2
Juho Jalkanen Chief Development Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 12,000
Value £8,520
Mehto Saima Kuolinpesä Chief Development Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 24,000
Value £17,040
2.2
Markku Jalkanen Chief Development Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 12,000
Value £8,520
1.4
Minja Pfeiffer Chief Development Officer Officer
Transaction date
Purchase
Price
0.57
Quantity 31,000
Value £17,670
1.0
Matti Karvonen Chief Executive Officer Officer
Through Matti Karvonen, a closely affiliated person
Transaction date
Purchase
Price
0.56
Quantity 15,000
Value £8,400
3.1
Pessi Honkasalo Medical Director Executive Director
Transaction date
Purchase
Price
0.75
Quantity 1,500
Value £1,125
3.3
Yrjö Wichmann Corporate Legal Counsel
Transaction date
Purchase
Price
0.67
Quantity 5,200
Value £3,484
Susanna Hedenström Chief Financial Officer Officer
Transaction date
Purchase
Price
0.56
Quantity 7,900
Value £4,424
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-31 2026-03-01 B Purchase
Tuomo Pätsi

Non-Executive Chairman

Director
59,740
13.79
€1,156,483 		59,740 13.79 €1,156,483
2026-03-25 2026-03-01 B Purchase
Sirpa Jalkanen

PCA
87,167
265.53
€1,791,182 		87,167 265.53 €1,791,182
2024-04-04 2024-04-03 B Purchase
Tuomo Pätsi

Director

Executive Director
12,958
258.14
€3,795,489 		12,958 258.14 €3,795,489
2024-04-04 2024-04-03 B Purchase
Sirpa Jalkanen

Director

Executive Director
79,999
1.50
€119,998 		79,999 1.50 €119,998
2024-04-04 2024-04-03 B Purchase
2.2
Markku Jalkanen

Director

Executive Director
79,999
1.50
€119,998 		79,999 1.50 €119,998
2023-10-27 2023-10-12 S Sale
John Poulos

Non-executive Director

Executive Director
5,000
3.83
€19,130 		5,000 3.83 €19,130
2023-10-27 2023-10-03 S Sale
John Poulos

Non-executive Director

Executive Director
5,000
3.72
€18,604 		5,000 3.72 €18,604
2022-04-08 2022-04-05 B Purchase
2.2
Markku Jalkanen

Chief Executive Officer

Officer
25,000
2.82
€70,532 		25,000 2.82 €70,532
2020-07-08 2020-07-08 B Purchase
2.4
Toni HÄonninen

Chief Financial Officer

Officer
4,400
3.51
£15,444 		4,400 3.51 £15,444
2020-05-12 2020-05-12 B Purchase
2.4
Toni HÄonninen

Chief Financial Officer

Officer
3,500
4.33
€15,139 		3,500 4.33 €15,139
2018-11-06 2018-10-26 B Purchase
1.0
Matti Karvonen

VP Drug Development, Chief Medical Officer

Officer
20,000
0.83
£16,580 		20,000 0.83 £16,580
2018-09-18 2018-09-17 B Purchase
1.4
Minja Pfeiffer

Chief Medical Officer

Officer
4,414
1.00
£4,414 		4,414 1.00 £4,414
2018-06-21 2018-06-21 B Purchase
3.2
Juho Jalkanen

Chief Development Officer

Officer
12,000
0.71
£8,520 		12,000 0.71 £8,520
2018-06-21 2018-06-21 B Purchase Mehto Saima Kuolinpesä

Chief Development Officer

Officer
24,000
0.71
£17,040 		24,000 0.71 £17,040
2018-06-21 2018-06-21 B Purchase
2.2
Markku Jalkanen

Chief Development Officer

Officer
12,000
0.71
£8,520 		12,000 0.71 £8,520
2018-06-21 2018-06-21 B Purchase
1.4
Minja Pfeiffer

Chief Development Officer

Officer
31,000
0.57
£17,670 		31,000 0.57 £17,670
2018-06-21 2018-06-21 B Purchase
1.0
Matti Karvonen

Chief Executive Officer

Through Matti Karvonen, a closely affiliated person Officer
15,000
0.56
£8,400 		15,000 0.56 £8,400
2018-06-21 2018-06-21 B Purchase
3.1
Pessi Honkasalo

Medical Director

Executive Director
1,500
0.75
£1,125 		1,500 0.75 £1,125
2018-06-21 2018-06-21 B Purchase
3.3
Yrjö Wichmann

Corporate Legal Counsel
5,200
0.67
£3,484 		5,200 0.67 £3,484
2018-06-21 2018-06-21 B Purchase Susanna Hedenström

Chief Financial Officer

Officer
7,900
0.56
£4,424 		7,900 0.56 £4,424

See older Faron Pharmaceuticals Oy insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Faron Pharmaceuticals Oy history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Faron Pharmaceuticals Oy

More insider trades in Finland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe